Asia On The Move: Alliance Boots Partner Nanjing Pharma President Quits, BIO’s EVP Leaves For Celgene
This article was originally published in PharmAsia News
Nanjing Pharma has seen three top executive departures in recent months, which could impact its collaboration with U.K. pharmacy giant Alliance Boots. Meanwhile, personnel changes also took place at BIO, Mundipharma, Beigene, Catalent Pharma Solutions and Zhejiang FDA.
You may also be interested in...
Several newly repurposed drugs, including a Bayer antimalarial, have shown potential benefits against the new coronavirus, promoting China to add several to its latest revised treatment guidelines.
Amid the ongoing spread of the coronavirus outbreak, China turns to novel and repurposed antiviral drugs but also courts traditional medicines to ease public fear over the largely unknown threat.